Data / Crowdfunding / North Carolina / Cytex Therapeutics, Inc.
Cytex Therapeutics, Inc.: crowdfunding raise on StartEngine Capital, LLC, $10,000 to $1,070,000 (2022)
Cytex Therapeutics, Inc., a corporation in Durham, NC, filed a Form C with the SEC on October 26, 2022 to raise $10,000 to $1,070,000 in Series B-CF Non-Voting Common Stock through StartEngine Capital, LLC. The offering closed on January 24, 2023. In its most recent fiscal year it reported $1,366,195 in revenue and a net loss of $1,069,206, with 8 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.cytexortho.com
- Funding portal
- StartEngine Capital, LLC
- Address
- 2609 N. DUKE STREET, SUITE 303A SUITE 303A, Durham, NC 27704
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- July 21, 2006
- SEC CIK
- 0001943908
Offering terms
From the offering filed October 26, 2022.
- Security
- Series B-CF Non-Voting Common Stock
- Price
- $2.00
- Target
- $10,000
- Maximum
- $1,070,000
- Deadline
- January 24, 2023
- Portal compensation
- 7 - 13 percent
Financials
From the Form C-AR filed May 2, 2025.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $1,366,195 | $1,284,927 | sec.gov |
| Cost of goods sold | $985,982 | $858,498 | sec.gov |
| Net income | $-1,069,206 | $-1,214,922 | sec.gov |
| Taxes paid | $-2,186 | $-10,845 | sec.gov |
| Total assets | $536,278 | $385,279 | sec.gov |
| Cash | $249,960 | $170,770 | sec.gov |
| Accounts receivable | $45,658 | $57,591 | sec.gov |
| Short-term debt | $231,628 | $192,787 | sec.gov |
| Long-term debt | $957,036 | $575,135 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| May 8, 2025 | Termination of reporting | Not listed | Not listed | sec.gov | ||
| May 2, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| April 29, 2024 | Annual report | Not listed | Not listed | sec.gov | ||
| May 1, 2023 | Annual report | Not listed | Not listed | sec.gov | ||
| January 27, 2023 | Progress update | $10,000 | $1,070,000 | January 24, 2023 | At the close of the offering, the issuer closed on $304,028.94 and 182,726 number of securities. | sec.gov |
| October 26, 2022 | Offering | $10,000 | $1,070,000 | January 24, 2023 | sec.gov |
Also on SpecStream
Updated May 8, 2025. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.